Tomasz Kucharczyk

566 total citations
30 papers, 386 citations indexed

About

Tomasz Kucharczyk is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Tomasz Kucharczyk has authored 30 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Tomasz Kucharczyk's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Tomasz Kucharczyk is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Tomasz Kucharczyk collaborates with scholars based in Poland, United States and Sweden. Tomasz Kucharczyk's co-authors include Paweł Krawczyk, Janusz Milanowski, Tomasz Powrózek, Kamila Wojas‐Krawczyk, Bożena Jarosz, Radosław Mlak, Justyna Szumiło, Anna Grenda, Rodryg Ramlau and Dariusz M. Kowalski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tomasz Kucharczyk

29 papers receiving 383 citations

Peers

Countries citing papers authored by Tomasz Kucharczyk

Since Specialization

Citations

This map shows the geographic impact of Tomasz Kucharczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Kucharczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Kucharczyk more than expected).

Fields of papers citing papers by Tomasz Kucharczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Kucharczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Kucharczyk. The network helps show where Tomasz Kucharczyk may publish in the future.

Co-authorship network of co-authors of Tomasz Kucharczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Kucharczyk. A scholar is included among the top collaborators of Tomasz Kucharczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Kucharczyk. Tomasz Kucharczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NRG1 Gene Fusions—What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications 2024 ·Cancers ·Tomasz Kucharczyk, Marcin Nicoś, (unknown), Ewa Kalinka‐Warzocha	0
2	Obesity and lung cancer – is programmed death ligand-1 (PD-1L) expression a connection? 2024 ·Archives of Medical Science ·(unknown), Marcin Czeczelewski, Tomasz Kucharczyk, (unknown), Sławomir Mańdziuk	1
3	Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer 2022 ·AMB Express ·Anna Grenda, (unknown), Izabela Chmielewska, Paweł Krawczyk, (unknown), Arkadiusz Bomba, (unknown), (unknown), Michał Szczyrek, Robert Kieszko, Tomasz Kucharczyk, Bożena Jarosz, Dariusz Wasyl, Janusz Milanowski	42
4	Deep learning-based tumor microenvironment segmentation is predictive of tumor mutations and patient survival in non-small-cell lung cancer 2022 ·BMC Cancer ·Alicja Rączkowska, (unknown), (unknown), Marcin Nicoś, Magdalena A. Budzinska, Tomasz Kucharczyk, Justyna Szumiło, Paweł Krawczyk, Nicola Crosetto, Ewa Szczurek	16
5	Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients 2022 ·Cancers ·Anna Grenda, (unknown), Paweł Krawczyk, (unknown), Izabela Chmielewska, Arkadiusz Bomba, (unknown), (unknown), Michał Szczyrek, Robert Kieszko, Tomasz Kucharczyk, Bożena Jarosz, Dariusz Wasyl, Janusz Milanowski	18
6	Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement 2021 ·Scientific Reports ·Paweł Krawczyk, Anna Grenda, (unknown), (unknown), Kamila Wojas‐Krawczyk, Tomasz Kucharczyk, Izabela Chmielewska, Robert Kieszko, Bożena Jarosz, (unknown), (unknown), Janusz Milanowski	6
7	Acute hypersensitivity pneumonitis in woodworkers caused by inhalation of birch dust contaminated with <i>Pantoea agglomerans</i> and <i>Microbacterium barkeri</i> 2019 ·Annals of Agricultural and Environmental Medicine ·Barbara Maćkiewicz, Jacek Dutkiewicz, (unknown), Tomasz Kucharczyk, (unknown), Angelina Wójcik‐Fatla, Grażyna Cholewa, (unknown), Mariola Paściak, Krzysztof Pawlik, Bogumiła Szponar, Janusz Milanowski	8
8	Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients 2018 ·Journal of Thoracic Disease ·Anna Grenda, Bożena Jarosz, Paweł Krawczyk, Tomasz Kucharczyk, Kamila Wojas‐Krawczyk, (unknown), (unknown), Marcin Nicoś, Juliusz Pankowski, Maciej Bryl, Rodryg Ramlau, Barbara Kuźnar-Kamińska, Tomasz Grodzki, Aleksandra Szczęsna, (unknown), Justyna Szumiło, Halina Batura‐Gabryel, (unknown), Janusz Milanowski	7
9	Do we apply a personalised lung cancer therapy? Use of molecular tests in scheduling a multilineage treatment in a patient with lung adenocarcinoma 2017 ·Oncology in Clinical Practice ·Marcin Nicoś, Paweł Krawczyk, Michał Szczyrek, Sławomir Mańdziuk, Bożena Jarosz, Kamila Wojas‐Krawczyk, Tomasz Kucharczyk, (unknown), Janusz Milanowski	1
10	The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients 2015 ·Pathology & Oncology Research ·Tomasz Kucharczyk, Paweł Krawczyk, Tomasz Powrózek, Dariusz M. Kowalski, Rodryg Ramlau, Ewa Kalinka‐Warzocha, (unknown), (unknown), Maciej Krzakowski, Janusz Milanowski	6
11	Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients 2014 ·Clinical Lung Cancer ·Tomasz Powrózek, Dariusz M. Kowalski, Paweł Krawczyk, Rodryg Ramlau, Tomasz Kucharczyk, Ewa Kalinka‐Warzocha, (unknown), (unknown), Wojciech Dyszkiewicz, Maciej Krzakowski, Janusz Milanowski	4
12	Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients 2014 ·Journal of Cancer Research and Clinical Oncology ·Paweł Krawczyk, Tomasz Kucharczyk, Dariusz M. Kowalski, Tomasz Powrózek, Rodryg Ramlau, Ewa Kalinka‐Warzocha, (unknown), (unknown), Kamila Wojas‐Krawczyk, (unknown), Wojciech Dyszkiewicz, Maciej Krzakowski, Janusz Milanowski	25
13	EGFRgene mutations in patients with adenosquamous lung carcinoma 2014 ·Asia-Pacific Journal of Clinical Oncology ·Tomasz Powrózek, Paweł Krawczyk, Rodryg Ramlau, (unknown), Kamila Wojas‐Krawczyk, Tomasz Kucharczyk, (unknown), Justyna Szumiło, (unknown), Piotr Milecki, (unknown), Janusz Milanowski	15
14	Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report 2014 ·Medical Oncology ·Tomasz Powrózek, Paweł Krawczyk, Tomasz Kucharczyk, Janusz Milanowski	81
15	Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients 2013 ·Oncology Reports ·Radosław Mlak, Paweł Krawczyk, Rodryg Ramlau, Ewa Kalinka‐Warzocha, (unknown), Kamila Wojas‐Krawczyk, Tomasz Kucharczyk, (unknown), (unknown), Marzanna Ciesielka, (unknown), Janusz Milanowski	23
16	EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report 2013 ·Clinical & Experimental Metastasis ·Kamila Wojas‐Krawczyk, (unknown), (unknown), (unknown), Tomasz Kucharczyk, Bożena Jarosz, Radosław Mlak, Justyna Szumiło, Marek Sawicki, Tomasz Trojanowski, (unknown), (unknown)	14
17	Predictive value of ERCC1 single-nucleotide polymorphism in patients receiving platinum-based chemotherapy for locally-advanced and advanced non-small cell lung cancer — a pilot study 2012 ·SHILAP Revista de lepidopterología ·Janusz Milanowski, Beata Biernacka, Radosław Mlak, Tomasz Kucharczyk, Kamila Wojas‐Krawczyk, Paweł Krawczyk	1
18	The Qualification of Docetaxel or Erlotinib for Second-Line Therapy Should Be Based on Clinical and Molecular Predictive Factors 2012 ·Chemotherapy ·Paweł Krawczyk, Dariusz M. Kowalski, Kamila Wojas‐Krawczyk, Radosław Mlak, (unknown), Tomasz Kucharczyk, (unknown), Maciej Krzakowski, Janusz Milanowski	15
19	The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients 2011 ·European Journal of Cancer Prevention ·Kamila Wojas‐Krawczyk, Paweł Krawczyk, Beata Biernacka, Maciej Grzybek, Przemysław Kołodziej, Tomasz Kucharczyk, Radosław Mlak, Janusz Milanowski	10
20	The Applicability of a Predictive Index for Second- and Third-Line Treatment of Unselected Non-Small-Cell Lung Cancer Patients 2011 ·Respiration ·Kamila Wojas‐Krawczyk, Paweł Krawczyk, Radosław Mlak, Tomasz Kucharczyk, Dariusz M. Kowalski, Maciej Krzakowski, Janusz Milanowski	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact